Ohgaki, H.

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

Wischhusen, J., Naumann, U., Ohgaki, H., Rastinejad, F., & Weller, M. (2003) · Oncogene

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 158

p53 Mutations in sporadic adrenocortical tumors

Ohgaki, H., Kleihues, P., & Heitz, P. U. (1993) · International Journal of Cancer

Adrenal and Paraganglionic TumorsCancer-related Molecular Pathways

Cited by 139

Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity

Baumgarten, P., Harter, P. N., Tönjes, M., Capper, D., Blank, A. ‐., Sahm, F., von Deimling, A., Kolluru, V., Schwamb, B., Rabenhorst, U., et al. (2014) · Neuropathology and Applied Neurobiology

Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 53